Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration.
Low Confidence ObservationalPrimary source: [Open]
Linked compounds: sermorelin
Outcomes summary
Pharmacokinetic and pharmacodynamic study in healthy men reporting that GHRH(1–29)-NH2 (sermorelin) is rapidly eliminated after intravenous administration, with associated growth hormone release; intranasal administration showed low bioavailability in this study.
Limitations
Older, early-phase physiology study; results may not generalize to clinical populations; dosing and routes studied are not guidance.
Notes
Primary source: PMID 8329825.